Document is current
Any future updates will be listed below
-
Authors
Srinivasan, Shriya https://orcid.org/0000-0002-2508-1324
Antonini, Marc-Joseph https://orcid.org/0000-0002-9774-1483
Alshareef, Amro https://orcid.org/0000-0001-8813-2531
Sahasrabudhe, Atharva https://orcid.org/0000-0002-2615-2470
Jenkins, Josh https://orcid.org/0000-0001-7698-9888
Ishida, Keiko
Kuosmanen, Johannes
Hayward, Alison
Min, Seokkee https://orcid.org/0000-0002-7308-6840
Langer, Robert https://orcid.org/0000-0003-4255-0492
Anikeeva, Polina https://orcid.org/0000-0001-6495-5197
Traverso, Giovanni https://orcid.org/0000-0001-7851-4077
- License Information
-
More Information
Article History
Received: 27 June 2023
Accepted: 17 July 2025
First Online: 10 August 2025
Competing interests
: Shriya Srinivasan, Marc-Joseph Antonini, Polina Anikeeva, Robert Langer, and Giovanni Traverso are co-inventors on provisional patent applications describing the developments presented here. R.L. and G.T. Report receiving consulting fees from Novo Nordisk. Complete details of all relationships for profit and not for profit for G.T. and R.L can be found at as supplemental attachments. All authors have submitted an invention disclosure to MIT. M.-J.A. and P.A. are cofounders of NeuroBionics Inc. that seeks to translate fibre-based technology to treatment of neurological conditions.
